155 related articles for article (PubMed ID: 18160406)
1. Crystal structure of lactadherin C2 domain at 1.7A resolution with mutational and computational analyses of its membrane-binding motif.
Shao C; Novakovic VA; Head JF; Seaton BA; Gilbert GE
J Biol Chem; 2008 Mar; 283(11):7230-41. PubMed ID: 18160406
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII.
Lin L; Huai Q; Huang M; Furie B; Furie BC
J Mol Biol; 2007 Aug; 371(3):717-24. PubMed ID: 17583728
[TBL] [Abstract][Full Text] [Related]
3. Membrane-binding properties of the Factor VIII C2 domain.
Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE
Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768
[TBL] [Abstract][Full Text] [Related]
4. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.
Shi J; Heegaard CW; Rasmussen JT; Gilbert GE
Biochim Biophys Acta; 2004 Nov; 1667(1):82-90. PubMed ID: 15533308
[TBL] [Abstract][Full Text] [Related]
5. Functional analyses of two cellular binding domains of bovine lactadherin.
Andersen MH; Graversen H; Fedosov SN; Petersen TE; Rasmussen JT
Biochemistry; 2000 May; 39(20):6200-6. PubMed ID: 10821695
[TBL] [Abstract][Full Text] [Related]
6. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.
Shi J; Gilbert GE
Blood; 2003 Apr; 101(7):2628-36. PubMed ID: 12517809
[TBL] [Abstract][Full Text] [Related]
7. Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion.
Taylor MR; Couto JR; Scallan CD; Ceriani RL; Peterson JA
DNA Cell Biol; 1997 Jul; 16(7):861-9. PubMed ID: 9260929
[TBL] [Abstract][Full Text] [Related]
8. NMR solution structure of C2 domain of MFG-E8 and insights into its molecular recognition with phosphatidylserine.
Ye H; Li B; Subramanian V; Choi BH; Liang Y; Harikishore A; Chakraborty G; Baek K; Yoon HS
Biochim Biophys Acta; 2013 Mar; 1828(3):1083-93. PubMed ID: 23262193
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.
Meems H; Meijer AB; Cullinan DB; Mertens K; Gilbert GE
Blood; 2009 Oct; 114(18):3938-46. PubMed ID: 19687511
[TBL] [Abstract][Full Text] [Related]
10. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains.
Pellequer JL; Gale AJ; Griffin JH; Getzoff ED
Blood Cells Mol Dis; 1998 Dec; 24(4):448-61. PubMed ID: 9880241
[TBL] [Abstract][Full Text] [Related]
11. Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.
Liu Z; Lin L; Yuan C; Nicolaes GA; Chen L; Meehan EJ; Furie B; Furie B; Huang M
J Biol Chem; 2010 Mar; 285(12):8824-9. PubMed ID: 20089867
[TBL] [Abstract][Full Text] [Related]
12. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
Gilbert GE; Novakovic VA; Kaufman RJ; Miao H; Pipe SW
Blood; 2012 Aug; 120(9):1923-32. PubMed ID: 22613792
[TBL] [Abstract][Full Text] [Related]
13. Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition.
Civra A; Giuffrida MG; Donalisio M; Napolitano L; Takada Y; Coulson BS; Conti A; Lembo D
J Biol Chem; 2015 May; 290(19):12403-14. PubMed ID: 25814665
[TBL] [Abstract][Full Text] [Related]
14. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
[TBL] [Abstract][Full Text] [Related]
15. New insights into binding interfaces of coagulation factors V and VIII and their homologues lessons from high resolution crystal structures.
Fuentes-Prior P; Fujikawa K; Pratt KP
Curr Protein Pept Sci; 2002 Jun; 3(3):313-39. PubMed ID: 12188899
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS.
Pantazatos D; Gessner CR; Woods VL; Gilbert GE
Biochem J; 2014 Aug; 461(3):443-51. PubMed ID: 24814520
[TBL] [Abstract][Full Text] [Related]
17. Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII.
Peters SC; Childers KC; Mitchell CE; Avery NG; Reese SS; Mitchell C; Wo SW; Swanson CD; Brison CM; Spiegel PC
Front Mol Biosci; 2022; 9():1040106. PubMed ID: 36387287
[TBL] [Abstract][Full Text] [Related]
18. Additional binding sites for anionic phospholipids and calcium ions in the crystal structures of complexes of the C2 domain of protein kinase calpha.
Ochoa WF; Corbalán-Garcia S; Eritja R; Rodríguez-Alfaro JA; Gómez-Fernández JC; Fita I; Verdaguer N
J Mol Biol; 2002 Jul; 320(2):277-91. PubMed ID: 12079385
[TBL] [Abstract][Full Text] [Related]
19. Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs.
Gilbert GE; Kaufman RJ; Arena AA; Miao H; Pipe SW
J Biol Chem; 2002 Feb; 277(8):6374-81. PubMed ID: 11698391
[TBL] [Abstract][Full Text] [Related]
20. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid.
Häggqvist B; Näslund J; Sletten K; Westermark GT; Mucchiano G; Tjernberg LO; Nordstedt C; Engström U; Westermark P
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8669-74. PubMed ID: 10411933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
